Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-11-14 Sale | 2024-11-15 6:23 pm | Equillium Inc. | EQ | Keyes Jason A Chief Financial Officer | 10,000 | $0.7 | $7,000 | 121,633 (Indirect Direct) | View |
2024-09-26 Sale | 2024-09-27 7:38 pm | Equillium Inc. | EQ | Keyes Jason A Chief Financial Officer | 10,000 | $0.81 | $8,100 | 131,633 (Indirect Direct) | View |
2024-07-16 Sale | 2024-07-18 5:52 pm | Equillium Inc. | EQ | Keyes Jason A Chief Financial Officer | 10,000 | $0.87 | $8,700 | 141,633 (Indirect Direct) | View |
2022-08-29 Sale | 2022-08-30 5:57 pm | Equillium Inc. | EQ | Keyes Jason A Chief Financial Officer | 7,000 | $2.83 | $19,810 | 108,384 (Indirect Direct) | View |
2022-06-06 Sale | 2022-06-06 9:17 pm | Equillium Inc. | EQ | Keyes Jason A Chief Financial Officer | 5,000 | $2.52 | $12,600 | 108,016 (Indirect Direct) | View |
2022-04-04 Sale | 2022-04-05 5:40 pm | Equillium Inc. | EQ | Keyes Jason A Chief Financial Officer | 8,000 | $3.18 | $25,440 | 113,016 (Indirect Direct) | View |
2021-12-01 Sale | 2021-12-03 1:57 pm | Equillium Inc. | EQ | Keyes Jason A Chief Financial Officer | 5,000 | $5.0803 | $25,402 | 115,431 (Indirect Direct) | View |
2021-09-27 Sale | 2021-09-29 1:02 pm | Equillium Inc. | EQ | Keyes Jason A Chief Financial Officer | 8,000 | $6.7405 | $53,924 | 120,431 (Indirect Direct) | View |
2021-07-27 Sale | 2021-07-28 11:55 am | Equillium Inc. | EQ | Keyes Jason A Chief Financial Officer | 5,000 | $5.717 | $28,585 | 128,431 (Indirect Direct) | View |
2021-05-26 Sale(A) | 2021-05-28 7:03 pm | Equillium Inc. | EQ | Keyes Jason A Chief Financial Officer | 5,000 | $6.4967 | $32,484 | 127,896 (Indirect Direct) | View |
2021-05-26 Sale | 2021-05-28 6:20 pm | Equillium Inc. | EQ | Keyes Jason A Chief Financial Officer | 5,000 | $6.4967 | $32,484 | 115,720 (Indirect) | View |
2020-12-23 Sale | 2020-12-28 09:15 am | Equillium Inc. | EQ | Keyes Jason A Chief Financial Officer | 8,000 | $4.7392 | $37,914 | 132,896 (Indirect Direct) | View |
2020-02-18 Sale | 2020-02-19 5:48 pm | Equillium Inc. | EQ | Keyes Jason A Chief Financial Officer | 5,000 | $5.0275 | $25,138 | 130,520 (Indirect) | View |
2020-01-21 Sale | 2020-01-22 8:13 pm | Equillium Inc. | EQ | Keyes Jason A Chief Financial Officer | 5,000 | $4.4086 | $22,043 | 135,520 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-08-12 Option Award | 2024-08-14 7:27 pm | N/A 2034-08-12 | ACTUATE THERAPEUTICS INC. | ACTU | Keyes Jason A Director | 30,000 | $0 | 30,000 (Direct) | View |
2024-01-02 Option Award | 2024-01-03 6:10 pm | N/A 2034-01-01 | Equillium Inc. | EQ | Keyes Jason A Chief Financial Officer | 175,000 | $0 | 311,633 (Direct) | View |
2023-06-09 Option Award | 2024-01-03 6:10 pm | N/A N/A | Equillium Inc. | EQ | Keyes Jason A Chief Financial Officer | 15,000 | $0.56 | 311,633 (Direct) | View |
2023-12-08 Option Award | 2024-01-03 6:10 pm | N/A N/A | Equillium Inc. | EQ | Keyes Jason A Chief Financial Officer | 8,805 | $0.58 | 311,633 (Direct) | View |
2022-01-19 Option Award | 2023-02-07 6:45 pm | N/A 2032-01-18 | Equillium Inc. | EQ | Keyes Jason A Chief Financial Officer | 125,000 | $0 | 125,000 (Direct) | View |
2023-01-03 Option Award | 2023-01-04 6:50 pm | N/A 2033-01-02 | Equillium Inc. | EQ | Keyes Jason A Chief Financial Officer | 175,000 | $0 | 287,828 (Direct) | View |
2022-12-09 Option Award | 2023-01-04 6:50 pm | N/A N/A | Equillium Inc. | EQ | Keyes Jason A Chief Financial Officer | 4,444 | $1.19 | 287,828 (Direct) | View |
2022-06-22 Option Award | 2022-06-24 6:29 pm | N/A 2032-06-22 | Sesen Bio Inc. | SESN | Keyes Jason A Director | 105,000 | $0 | 105,000 (Direct) | View |
2021-12-10 Option Award | 2021-12-13 10:01 am | N/A N/A | Equillium Inc. | EQ | Keyes Jason A Chief Financial Officer | 5,585 | $2.35 | 121,016 (Direct) | View |
2021-06-10 Option Award | 2021-06-14 5:56 pm | N/A N/A | Equillium Inc. | EQ | Keyes Jason A Chief Financial Officer | 5,535 | $2.35 | 17,711 (Direct) | View |
2021-05-03 Option Award | 2021-05-05 6:22 pm | N/A 2031-05-03 | Sesen Bio Inc. | SESN | Keyes Jason A Director | 92,500 | $0 | 92,500 (Direct) | View |
2021-01-04 Option Award | 2021-01-06 5:00 pm | N/A 2031-01-03 | Equillium Inc. | EQ | Keyes Jason A Chief Financial Officer | 100,000 | $0 | 100,000 (Direct) | View |
2020-12-10 Other | 2020-12-11 5:00 pm | N/A N/A | Equillium Inc. | EQ | Keyes Jason A Chief Financial Officer | 5,362 | $2.35 | 146,258 (Direct) | View |
2020-06-10 Other | 2020-06-12 4:30 pm | N/A N/A | Equillium Inc. | EQ | Keyes Jason A Chief Financial Officer | 5,014 | $2.41 | 140,548 (Direct) | View |
2020-05-06 Option Award | 2020-05-08 5:52 pm | N/A 2030-05-06 | Sesen Bio Inc. | SESN | Keyes Jason A Director | 59,000 | $0 | 59,000 (Direct) | View |
2020-04-22 Disposition | 2020-04-24 5:33 pm | N/A 2029-02-12 | Equillium Inc. | EQ | Keyes Jason A Chief Financial Officer | 160,000 | $0 | 160,000 (Direct) | View |
2020-04-22 Option Award | 2020-04-24 5:33 pm | N/A 2029-02-12 | Equillium Inc. | EQ | Keyes Jason A Chief Financial Officer | 160,000 | $0 | 160,000 (Direct) | View |
2020-02-24 Option Award | 2020-02-26 5:25 pm | N/A 2030-02-24 | Sesen Bio Inc. | SESN | Keyes Jason A Director | 118,000 | $0 | 118,000 (Direct) | View |
2019-12-10 Option Award | 2019-12-12 5:57 pm | N/A 2029-12-09 | Equillium Inc. | EQ | Keyes Jason A Chief Financial Officer | 90,000 | $0 | 90,000 (Direct) | View |